MYCN and neuroblastoma: To identify metabolic pathways that are activated at the transcription level by MYCN, we performed microarray gene expression profiling of MYCN-responsive genes, using the non-MYCN-amplified neuroblastoma cell line SK-N-AS with inducible expression of MYCN in the absence of doxycycline [10].